• Ranolazine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.

    Active IngredientStrengthPrimary Clinical Function
    Ranolazine INN/Ph.Eur.500 mg (Extended-Release)Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily).
    Ranolazine INN/Ph.Eur.1000 mg (Extended-Release)Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation.
    ExcipientsHypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium StearateHydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).